TRPS1 and triple-negative breast carcinoma: With GATA3 and TRPS1, more specific breast cancer markers are available that showed 55.4% (GATA3, [33]) and 77.8% positivity (TRPS1, manuscript in revision) in triple-negative breast cancers in our tumor cohort.